BEIJING, China (AFP) — China on Saturday said it had given “conditional” approval for Pfizer’s Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease. The National Medical Products Administration said further research on the drug needed to be undertaken and submitted to the regulator. Paxlovid has so far been authorized in several countries including the United States and Israel, while the European Union […]